Article

The ELISA, enzyme-linked immunosorbent assay.

The Burnham Institute, La Jolla, CA, USA.
Clinical Chemistry (Impact Factor: 7.77). 10/2009; 56(2):319-20. DOI: 10.1373/clinchem.2009.127803
Source: PubMed
0 Bookmarks
 · 
387 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: An unclassifiedMycobacterium species has been isolated from two patients with Crohn's disease (CD). Antibodies to the unclassified mycobacteria cross-reacted withMycobacterium paratuberculosis. Because of this cross-reactivity, an enzyme-linked immunosorbent assay (ELISA) was used to examine the sera of inflammatory bowel disease (IBD) patients, both CD (N=56), and ulcerative colitis (UC) (N=34), for antibodies toM. paratuberculosis, Mycobacterium kansasii, andMycobacterium tuberculosis. Controls consisted of healthy, PPD-negative individuals (N=67), and from PPD-positive patients (N=41). Eighteen resected CD patients were also examined. CD patients had a statistically significant increase in antibody titer (P=0.0003) toM. paratuberculosis compared to healthy controls. Although patients with positive PPD had elevated titers to this organism, the positive response of CD patients was not related to PPD responsiveness, area of involvement in the gut, nor to activity of the disease process.
    Digestive Diseases and Sciences 12/1984; 29(12):1080-1085. · 2.55 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The thiazolidinedione (TZDs) class of drugs are very effective for the treatment of type 2 diabetes mellitus (T2DM). But due to the adverse effects of synthetic TZDs, their use is strictly regulated. The therapeutic actions of TZDs are mediated via modulation of peroxisome proliferator-activated receptor gamma (PPARγ). Naturally occurring PPARγ modulators are more desirable as they lack the serious adverse effects caused by TZDs. This has prompted the exploitation of medicinal plants used in traditional medicine, for their potential PPARγ activity. In the present work, we studied chebulagic acid (CHA) isolated from fruits of Terminalia chebula with respect to its effect on adipogenesis, glucose transport, and endocrine function of adipocyte. The mRNA expression profile of PPARγ target gene CCAAT/enhancer-binding protein alpha (C/EBP-α) was analyzed by qRT-PCR. The putative binding mode and the potential ligand-target interactions of CHA, with PPARγ was analyzed using docking software (Autodock and iGEMDOCKv2). The results showed that CHA enhances PPARγ signaling and adipogenesis dose dependently but in a moderate way, less than rosiglitazone. GLUT4 expression and adiponectin secretion was increased by CHA treatment. The mRNA expression of PPARγ target gene C/EBP-α was increased in CHA-treated adipocytes. The comparison of results of various parameters of adipogenesis, insulin sensitivity, endocrine function and molecular docking experiments of roziglitazone and chebulagic acid indicate that the latter behaves like partial PPARγ agonist which could be exploited for phytoceutical development against T2DM. © 2014 BioFactors, 2014.
    BioFactors 12/2014; · 3.09 Impact Factor
  • Source
    Autoimmune Diseases, Edited by James Chan, 01/2012: chapter 10: pages 43; INTECH., ISBN: 978-953-51-0693-7

Preview

Download
16 Downloads
Available from